Janus face of vascular endothelial growth factor: The obligatory survival factor for lung vascular endothelium controls precapillary artery remodeling in severe pulmonary hypertension

Critical Care Medicine

Volumn 30, Issue 5 SUPPL., 2002, Pages

  Voelkel, Norbert F ^a   Cool, Carlyne ^a   Taraceviene Stewart, Laima ^a   Geraci, Mark W ^a   Yeager, Michael ^a   Bull, Todd ^a   Kasper, Michael ^a   Tuder, Rubin M ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Apoptosis resistance; Endothelial cell phenotypes; Pulmonary circulation; Vascular endothelial growth factor; Vascular endothelial growth factor receptor blockade

Indexed keywords

MESSENGER RNA; PROTEIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

APOPTOSIS; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CONFERENCE PAPER; EMPHYSEMA; HEART FAILURE; HYPOXIA; LUNG CAPILLARY; LUNG DISEASE; LUNG ENDOTHELIUM; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; SHEAR STRESS;

EID: 0036245561     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200205001-00013     Document Type: Conference Paper

References (38)

1. Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension
2. Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell specific markers: Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth
3. The pathobiology of pulmonary hypertension
4. Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: Evidence for a process of disordered angiogenesis
5. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension
6. High expression of endothelial nitric oxide synthase in plexiform lesions of pulmonary hypertension
7. HOX genes in human lung: Altered exprestension: In primary pulmonary hypertension and emphysema
8. Primary vascular pulmonary hypertension: Report on 21 patients
9. Appetite-suppressant drugs and the risk of primary pulmonary hypertension
10. Anorexigens and pulmonary hypertension in the United Stated: Results from the surveillance of North American pulmonary hypertension
11. Fatal pulmonary hypertension associated with short-term use of fenfluramine and phentermine
12. Monoclonal endothelial cells in appetite suppressant-associated pulmonary hypertension
13. Serotonin produces both hyperplasia and hypertrophy of bovine pulmonary artery smooth muscle cells in culture
14. Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene
15. A role for potassium channels in smooth muscle cells and platelets in the etiology of primary pulmonary hypertension
16. Role of vascular injury and hemodynamics in rat pulmonary artery remodeling
17. Heterozygous germline mutations in BMPR2, encoding a TGF-B receptor, cause familiar pulmonary hypertension
18. Severe pulmonary hypertension after the discovery of the familial primary pulmonary hypertension gene
19. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension
20. The hallmarks of cancer
21. Vascular endothelial permeability/growth factor expression in plexogenic pulmonary arteriopathy
22. Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension
23. 5-Lipoxygenase and 5-lipoxygenase activating protein (FLAP) immunoreactivity in lungs from patients with primary pulmonary hypertension
24. Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension
25. Mutational analysis of endothelial cell TGF-b receptor type II in plexiform lesions of patients with primary pulmonary hypertension
26. Microsatellite instability of endothelial cell growth and apoptosis genes within plexiform lesions in primary pulmonary hypertension
27. Gene expression patterns in the lungs of patients with primary pulmonary hypertension: A gene microarray analysis
28. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway: Requirement for Flk-1/KDR activation
29. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells
30. VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAP/ERK and SAPK/JNK signaling
31. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema
32. Vascular endothelial cell growth factor-induced tissue factor expression in endothelial cells is mediated by EGR-1
33. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
34. Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery
35. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization
36. Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease: A randomized, controlled trial
37. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension
38. Cellular and molecular biology of vascular smooth muscle cells in pulmonary hypertension